IL1B |
P01584
|
interleukin 1 beta
|
|
0.13 |
0.276 |
0.962 |
SMN2 |
Q16637
|
survival of motor neuron 2, centromeric
|
|
0.10 |
0.459 |
0.769 |
NPPA |
P01160
|
natriuretic peptide A
|
|
5.5E-04 |
0.505 |
0.769 |
PKD1 |
P98161
|
polycystin 1, transient receptor potential channel interacting
|
|
1.00 |
0.493 |
0.769 |
POTEF |
A5A3E0
|
POTE ankyrin domain family member F
|
|
5.5E-06 |
0.481 |
0.885 |
ATP13A2 |
Q9NQ11
|
ATPase cation transporting 13A2
|
|
9.0E-09 |
0.566 |
0.577 |
SULT1A1 |
P50225
|
sulfotransferase family 1A member 1
|
|
3.0E-11 |
0.554 |
0.769 |
SPN |
P16150
|
sialophorin
|
|
1.4E-02 |
0.563 |
0.692 |
AGFG1 |
P52594
|
ArfGAP with FG repeats 1
|
|
0.99 |
0.569 |
0.769 |
EPM2A |
O95278
|
EPM2A glucan phosphatase, laforin
|
|
8.7E-06 |
0.608 |
0.577 |
CLN6 |
Q9NWW5
|
CLN6 transmembrane ER protein
|
|
1.0E-04 |
0.670 |
0.231 |
CLN8 |
Q9UBY8
|
CLN8 transmembrane ER and ERGIC protein
|
|
3.6E-03 |
0.682 |
0.423 |
MFSD8 |
Q8NHS3
|
major facilitator superfamily domain containing 8
|
|
2.5E-12 |
0.682 |
0.231 |
LAP |
|
Laryngeal adductor paralysis
|
|
|
0.619 |
0.731 |
TRIP10 |
Q15642
|
thyroid hormone receptor interactor 10
|
|
1.7E-05 |
0.650 |
0.654 |
CLN5 |
O75503
|
CLN5 intracellular trafficking protein
|
|
1.7E-08 |
0.705 |
0.269 |
SULT1A3 |
P0DMM9 P0DMN0
|
sulfotransferase family 1A member 3
|
|
0.36 |
0.722 |
0.500 |
SLX1A-SULT1A3 |
|
SLX1A-SULT1A3 readthrough (NMD candidate)
|
|
|
0.821 |
0.346 |
SULT1A4 |
P0DMM9 P0DMN0
|
sulfotransferase family 1A member 4
|
|
0.38 |
0.821 |
0.346 |
ATP5MC1 |
P05496
|
ATP synthase membrane subunit c locus 1
|
|
0.43 |
0.805 |
0.308 |
YIF1A |
O95070
|
Yip1 interacting factor homolog A, membrane trafficking protein
|
|
6.2E-10 |
0.890 |
0.192 |
CAPN8 |
A6NHC0
|
calpain 8
|
|
1.3E-13 |
0.861 |
0.192 |
CLN9 |
|
ceroid-lipofuscinosis, neuronal 9
|
|
|
0.890 |
0.115 |
ACTB |
P60709
|
actin beta
|
Cellular structure
|
0.99 |
0.325 |
0.923 |
HP |
P00738
|
haptoglobin
|
Enzyme
|
1.7E-05 |
0.412 |
0.885 |